Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 4.015
3.19 %
$ 264 M
Market Cap
-2.81
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Neuronetics, Inc.
| Revenue | 74.9 M |
| Cost Of Revenue | 20.7 M |
| Gross Profit | 54.2 M |
| Operating Expenses | 88.7 M |
| Operating Income | -34.6 M |
| Other Expenses | 8.64 M |
| Net Income | -43.2 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 74.9 | 71.3 | 65.2 | 55.3 | 49.2 | 62.7 | 52.8 | 40.4 | 34.2 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 20.7 | 19.6 | 15.5 | 11.7 | 11.6 | 15.4 | 12.4 | 9.6 | 6.6 |
| Gross Profit | 54.2 | 51.7 | 49.7 | 43.7 | 37.7 | 47.3 | 40.3 | 30.8 | 27.6 |
| OPERATING INCOME | |||||||||
| Operating Expenses | 88.7 | 82.3 | 84.8 | 71.2 | 60.0 | 74.2 | 60.2 | 44.4 | 36.9 |
| Selling, General and Administrative Expenses | 76.0 | 72.7 | 75.5 | 63.3 | 50.8 | 60.5 | 51.9 | 36.5 | 28.7 |
| Research and Development Expenses | 12.8 | 9.5 | 9.3 | 7.9 | 9.2 | 13.7 | 8.2 | 7.9 | 8.2 |
| Operating Income | (34.6) | (30.6) | (35.1) | (27.6) | (22.3) | (26.9) | (19.8) | (13.6) | (9.3) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 7.3 | 5.4 | 4.3 | 4.0 | 4.5 | 3.7 | 3.7 | 2.8 | 1.8 |
| Total Other Income | (9.2) | 0.4 | (2.0) | (3.6) | (5.1) | (2.1) | (4.3) | (2.5) | (1.9) |
| Pre-Tax Income | (43.7) | (30.2) | (37.2) | (31.2) | (27.5) | (29.0) | (24.1) | (16.1) | (11.2) |
| NET INCOME | |||||||||
| Tax Provision | 0 | 24 K | 2.0 | 4.4 | 4.8 | 5.3 | (0.6) | 3.2 | 1.8 |
| Net Income | (43.7) | (30.2) | (39.2) | (35.6) | (32.3) | (34.3) | (24.1) | (16.1) | (11.2) |
| EPS | 1.38 | 1.05 | 1.46 | 1.4 | 1.71 | 1.87 | 2.69 | 1.43 K | 1 K |